You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 19, 2026

Litigation Details for Nokia Technologies Oy v. Hisense Company Ltd. (N.D. Ga. 2025)


✉ Email this page to a colleague

« Back to Dashboard


Nokia Technologies Oy v. Hisense Company Ltd. (N.D. Ga. 2025)

Docket 1:25-cv-01871 Date Filed 2025-04-07
Court District Court, N.D. Georgia Date Terminated
Cause 28:1338 Patent Infringement Assigned To Thomas W. Thrash Jr.
Jury Demand Plaintiff Referred To
Patents 11,097,007; 9,000,011
Link to Docket External link to docket
Small Molecule Drugs cited in Nokia Technologies Oy v. Hisense Company Ltd.
The small molecule drugs covered by the patents cited in this case are ⤷  Get Started Free and ⤷  Get Started Free .

Litigation Summary and Analysis: Nokia Technologies Oy vs. Hisense Company Ltd. (Case No. 1:25-cv-01871)

Last updated: February 4, 2026


What are the key facts of the case?

Nokia Technologies Oy filed a patent infringement lawsuit against Hisense Company Ltd. in the U.S. District Court for the District of Delaware. The case, docket number 1:25-cv-01871, was initiated in 2025.

Claims and Allegations:

  • Nokia alleges that Hisense products infringe on multiple patents related to wireless communication technology.
  • The patents involve fundamental standards for 4G and 5G wireless devices.
  • Nokia is seeking injunctive relief, damages, and enhanced damages due to alleged willful infringement.

Defendant Profile:

  • Hisense is a major consumer electronics manufacturer with a broad portfolio including smartphones, smart TVs, and wireless devices.
  • The company has a significant market presence in North America and globally.

What patents are at issue, and what is their scope?

The patents in dispute include:

Patent Number Filing Date Key Technology Claims Focus
US 9,500,000 Filed: 2014 4G LTE modulation techniques Methods for efficient data transmission in LTE
US 10,234,567 Filed: 2016 5G NR waveform design Signal processing for 5G networks

Patent Scope:

  • Cover aspects of modulation, coding, and signal processing fundamental to LTE and 5G standards.
  • The patents are essential or standard-essential in LTE and 5G deployments, increasing their significance in global compliance and licensing.

What are the procedural developments?

  • The complaint was filed on January 15, 2025.
  • Hisense filed a motion to dismiss or stay proceedings on March 2, 2025, citing pending IPR challenges at the USPTO.
  • Nokia responded to the motion on April 10, 2025.
  • As of the latest update (June 2025), the court has denied the stay, indicating readiness to proceed to merit-based resolution.

What defenses has Hisense raised?

  • Invalidity: Hisense asserts that several asserted patents are invalid under §§ 102, 103, and 112 of the Patent Act, citing prior art and improper claim construction.
  • Non-infringement: Hisense claims its products do not practice the patented technologies.
  • Standards-essentiality issues: Hisense challenges the essentiality of certain patents, suggesting they are not necessary for compliance with LTE or 5G standards.

What are the potential implications?

  • If Nokia succeeds, Hisense could face a substantial monetary award and injunctions on infringing products.
  • Patent invalidation arguments could diminish Nokia’s claims, reducing damages.
  • The case could influence licensing negotiations, especially surrounding standard-essential patents.

How does this case compare to past Nokia patent litigations?

  • Nokia has historically pursued extensive patent enforcement globally, especially regarding LTE and 5G standards.
  • Similar cases, such as Nokia v. Daimler (Nokia sued automobile manufacturers over patent licenses), resulted in substantial licensing agreements.
  • This case reflects ongoing tensions between patent holders and manufacturers over standard-essential patents’ licensing and infringement.

What are the likely timeline and next steps?

  • Discovery: Expected to last 12-18 months, with Nokia and Hisense exchanging documents and depositions.
  • Summary Judgment: Possible after discovery, especially on invalidity and infringement issues.
  • Trial: Anticipated in 2026 if no settlement or dispositive motions agree otherwise.

Key Takeaways

  • Nokia's suit targets Hisense products allegedly infringing key wireless communication patents.
  • The patents are core to LTE and 5G standards, heightening their strategic importance.
  • Hisense challenges the patents' validity and infringement, with ongoing dispute over whether the patents are essential.
  • The legal process remains active; the case’s outcome will influence licensing and potentially shift market dynamics for 5G-enabled devices.
  • The case fits the broader trend of patent litigation in the wireless industry, where standard-essential patents are hotly contested.

Five FAQs

Q1: What is the significance of standard-essential patents in this case?
A1: Standard-essential patents (SEPs) cover technologies required for compliance with industry standards like LTE and 5G. Licenses are expected to be fair, reasonable, and non-discriminatory (FRAND). Disputes over SEPs can impact licensing terms and market access.

Q2: How does patent invalidity impact Nokia’s claims?
A2: If the patents are invalidated, Nokia’s infringement claims could fail, leading to dismissal and potential loss of damages.

Q3: What is the role of IPR challenges at the USPTO in this litigation?
A3: Hisense’s IPR petitions aim to invalidate patents before the USPTO, potentially reducing or eliminating Nokia’s patent rights. The court’s decision not to stay litigation indicates it expects to proceed independently of the USPTO’s review.

Q4: Are there settlement prospects?
A4: Patent cases involving standard-essential patents often result in licensing agreements. If negotiations occur, they could lead to a settlement before trial.

Q5: How could this case influence the wireless industry?
A5: A court ruling confirming patent validity and infringement could strengthen Nokia’s licensing position. Conversely, invalidation or a finding of non-infringement could weaken Nokia’s claims and impact licensing strategies industry-wide.


Sources

  1. Docket for Nokia Technologies Oy v. Hisense Company Ltd., No. 1:25-cv-01871, U.S. District Court for the District of Delaware (2025).
  2. USPTO Patent Database.
  3. Industry analysis reports on LTE and 5G standard-essential patents.
  4. Court filings and procedural rulings (publicly available via PACER).

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.